Rituximab-induced vasculitis: A case report and review of the medical published work

Min Joo Kim; Hyung Ok Kim; Ho Yeon Kim; Young Min Park

doi:10.1111/j.1346-8138.2009.00639.x

Rituximab-induced vasculitis: A case report and review of the medical published work

Min Joo Kim
, Hyung Ok Kim
, Ho Yeon Kim
, Young Min Park

Department of Dermatology

The Catholic University of Korea

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

Rituximab is an anti-CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side-effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the English language medical published work. We describe a 38-year-old Korean man with cutaneous vasculitis occurring 1 day after rituximab administration.

Original language	English
Pages (from-to)	284-287
Number of pages	4
Journal	Journal of Dermatology
Volume	36
Issue number	5
DOIs	https://doi.org/10.1111/j.1346-8138.2009.00639.x
State	Published - May 2009

Keywords

Rituximab
Side effects
Vasculitis

Access to Document

10.1111/j.1346-8138.2009.00639.x

Cite this

@article{baca4bee51b243d39aeeabdd0f309a4a,

title = "Rituximab-induced vasculitis: A case report and review of the medical published work",

abstract = "Rituximab is an anti-CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side-effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the English language medical published work. We describe a 38-year-old Korean man with cutaneous vasculitis occurring 1 day after rituximab administration.",

keywords = "Rituximab, Side effects, Vasculitis",

author = "Kim, \{Min Joo\} and Kim, \{Hyung Ok\} and Kim, \{Ho Yeon\} and Park, \{Young Min\}",

year = "2009",

month = may,

doi = "10.1111/j.1346-8138.2009.00639.x",

language = "English",

volume = "36",

pages = "284--287",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Rituximab-induced vasculitis

T2 - A case report and review of the medical published work

AU - Kim, Min Joo

AU - Kim, Hyung Ok

AU - Kim, Ho Yeon

AU - Park, Young Min

PY - 2009/5

Y1 - 2009/5

N2 - Rituximab is an anti-CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side-effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the English language medical published work. We describe a 38-year-old Korean man with cutaneous vasculitis occurring 1 day after rituximab administration.

AB - Rituximab is an anti-CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side-effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the English language medical published work. We describe a 38-year-old Korean man with cutaneous vasculitis occurring 1 day after rituximab administration.

KW - Rituximab

KW - Side effects

KW - Vasculitis

UR - https://www.scopus.com/pages/publications/65249176956

U2 - 10.1111/j.1346-8138.2009.00639.x

DO - 10.1111/j.1346-8138.2009.00639.x

M3 - Article

C2 - 19382999

AN - SCOPUS:65249176956

SN - 0385-2407

VL - 36

SP - 284

EP - 287

JO - Journal of Dermatology

JF - Journal of Dermatology

IS - 5

ER -

Rituximab-induced vasculitis: A case report and review of the medical published work

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this